AbbVie board backs away from Shire deal over new tax rules

AbbVie’s board is telling shareholders to vote against its own $55-billion US takeover bid for the Irish drugmaker Shire after the U.S. made reincorporating overseas a less lucrative tax maneuvre. Read entire story.

Source: CBC | Business News